- Home
- VSEC vs VKTX Comparison
VSEC vs VKTX Comparison
Compare VSEC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- VKTX
- Stock Information
- Founded
- VSEC 1959
- VKTX 2012
- Country
- VSEC United States
- VKTX United States
- Employees
- VSEC N/A
- VKTX N/A
- Industry
- VSEC Military/Government/Technical
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- VKTX Health Care
- Exchange
- VSEC Nasdaq
- VKTX Nasdaq
- Market Cap
- VSEC 3.4B
- VKTX 3.8B
- IPO Year
- VSEC N/A
- VKTX 2015
- Fundamental
- Price
- VSEC $168.22
- VKTX $34.40
- Analyst Decision
- VSEC Strong Buy
- VKTX Strong Buy
- Analyst Count
- VSEC 5
- VKTX 14
- Target Price
- VSEC $196.80
- VKTX $87.07
- AVG Volume (30 Days)
- VSEC 331.3K
- VKTX 4.3M
- Earning Date
- VSEC 10-27-2025
- VKTX 10-22-2025
- Dividend Yield
- VSEC 0.24%
- VKTX N/A
- EPS Growth
- VSEC N/A
- VKTX N/A
- EPS
- VSEC 0.54
- VKTX N/A
- Revenue
- VSEC $1,332,372,000.00
- VKTX N/A
- Revenue This Year
- VSEC $3.14
- VKTX N/A
- Revenue Next Year
- VSEC $16.88
- VKTX N/A
- P/E Ratio
- VSEC $308.99
- VKTX N/A
- Revenue Growth
- VSEC 67.77
- VKTX N/A
- 52 Week Low
- VSEC $88.69
- VKTX $18.92
- 52 Week High
- VSEC $186.00
- VKTX $56.25
- Technical
- Relative Strength Index (RSI)
- VSEC 46.62
- VKTX 44.88
- Support Level
- VSEC $162.95
- VKTX $34.67
- Resistance Level
- VSEC $174.50
- VKTX $43.15
- Average True Range (ATR)
- VSEC 7.01
- VKTX 2.70
- MACD
- VSEC -1.56
- VKTX -0.69
- Stochastic Oscillator
- VSEC 25.46
- VKTX 13.85
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.